Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised disease.
Ploussard G, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Dariane C, Mathieu R, Rozet F, Peyrottes A, Roubaud G, Renard-Penna R, Sargos P, Supiot S, Turpin L, Rouprêt M; Comité de Cancérologie de l’Association Française d’Urologie, Groupe Prostate, Maison de l’Urologie. Ploussard G, et al. Among authors: sargos p. Fr J Urol. 2024 Nov;34(12):102717. doi: 10.1016/j.fjurol.2024.102717. Fr J Urol. 2024. PMID: 39581668 Review.
French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistance.
Ploussard G, Dariane C, Mathieu R, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Rozet F, Peyrottes A, Renard-Penna R, Sargos P, Supiot S, Turpin L, Roubaud G, Rouprêt M; Comité de Cancérologie de l’Association Française d’Urologie, Groupe Prostate, Maison de l’Urologie. Ploussard G, et al. Among authors: sargos p. Fr J Urol. 2024 Nov;34(12):102710. doi: 10.1016/j.fjurol.2024.102710. Fr J Urol. 2024. PMID: 39581665 Review.
French AFU Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer.
Bigot P, Boissier R, Khene ZE, Albigès L, Bernhard JC, Correas JM, De Vergie S, Doumerc N, Ferragu M, Ingels A, Margue G, Ouzaïd I, Pettenati C, Rioux-Leclercq N, Sargos P, Waeckel T, Barthelemy P, Rouprêt M. Bigot P, et al. Among authors: sargos p. Fr J Urol. 2024 Nov;34(12):102735. doi: 10.1016/j.fjurol.2024.102735. Fr J Urol. 2024. PMID: 39581661 Free article. Review.
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Bossi A, Foulon S, Maldonado X, Sargos P, MacDermott R, Kelly P, Fléchon A, Tombal B, Supiot S, Berthold D, Ronchin P, Kacso G, Salem N, Calabro F, Berdah JF, Hasbini A, Silva M, Boustani J, Ribault H, Fizazi K; PEACE-1 investigators. Bossi A, et al. Among authors: sargos p. Lancet. 2024 Nov 23;404(10467):2065-2076. doi: 10.1016/S0140-6736(24)01865-8. Lancet. 2024. PMID: 39580202 Clinical Trial.
Concomitant chemotherapy in trimodal treatment of patients with muscle invasive bladder cancer: A systematic review of prospective trials.
Baudelin C, Sargos P, Dinart D, Hennequin C, Teyssonneau D, Meynard L, Vuong NS, Lefort F, Baboudjian M, Roubaud G. Baudelin C, et al. Among authors: sargos p. Crit Rev Oncol Hematol. 2024 Nov 22;205:104557. doi: 10.1016/j.critrevonc.2024.104557. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 39580059 Review.
Anatomic Factors Associated with Complications After Radical Prostatectomy: A Systematic Review and Meta-analysis.
Peyrottes A, Dariane C, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Mathieu R, Olivier J, Renard-Penna R, Roubaud G, Rouprêt M, Sargos P, Supiot S, de la Taille A, Turpin L, Desgrandchamps F, Ploussard G, Masson-Lecomte A; French Oncology Committee from the Association Française d’Urologie. Peyrottes A, et al. Among authors: sargos p. Eur Urol Oncol. 2024 Nov 18:S2588-9311(24)00247-5. doi: 10.1016/j.euo.2024.10.018. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39562217 Review.
Radiation therapy for stage IIA/IIB seminomas: Back to the future?
Le Guévelou J, Nicosia L, Blanchard P, Ralite F, Durand X, Marchesi V, Roubaud G, Sargos P. Le Guévelou J, et al. Among authors: sargos p. Radiother Oncol. 2024 Nov 16;202:110626. doi: 10.1016/j.radonc.2024.110626. Online ahead of print. Radiother Oncol. 2024. PMID: 39557127
Heart is a heavy burden: cardiac toxicity in radiation oncology.
Pouvreau P, Taleb I, Fontaine A, Edouard L, Gibson N, Yaouanq M, Boudoussier A, Petit A, Vinh-Hung V, Sargos P, Benziane-Ouaritini N, Bouleftour W, Magne N. Pouvreau P, et al. Among authors: sargos p. Support Care Cancer. 2024 Nov 4;32(11):769. doi: 10.1007/s00520-024-08949-7. Support Care Cancer. 2024. PMID: 39495349 Review.
208 results